MedTrace Logo

DermAI to Evaluate Human Factor of Testing

NCT06387472 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 151

Last updated 2025-09-10

Study results available
· View outcomes & findings →

Summary

The purpose of this research is to improve how well remote patch allergy testing works and make sure they are easy and practical for people to use from home.

Conditions

  • Contact Dermatitis

Interventions

DEVICE

AI algorithm to evaluate photographs of skin test patch regions

Interpretation of skin test patch regions via artificial intelligence (AI)

DEVICE

Allergen Patch

Contains dime-sized disks which have different substance to which a person may be allergic. Two different patches were used due to the number of allergens being tested. Each patch can only hold 10 allergens and 14 allergens were tested in patients.

Sponsors & Collaborators

Principal Investigators

  • Matthew Hall, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-08
Primary Completion
2024-08-23
Completion
2024-12-13
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06387472 on ClinicalTrials.gov